Teva temporarily padlocks a plant after FDA cites it for contamination
After FDA investigators unveiled a list of problems that were found at a Teva Pharmaceuticals plant in Irvine, CA, including mold stemming from water leaks, the company said it will halt production at that site until it is able to meet quality expectations.
A Teva spokesperson confirmed the temporary manufacturing stoppage Monday morning in an email to Endpoints News, saying that that production will resume after a review is conducted.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.